Rwanda Biomedical Center Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
2014
NCT02104700
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Rwanda Biomedical Center | Rwanda Biomedical Center (RBC)